Health
U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…
By Reuters Staff
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very significant work with the company to figure out if theres a significant safety issue or not, FDA Commissioner Stephen H…
-
Noosa News18 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General18 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News10 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
General7 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania